Skip to content

Biohaven BHVN Price / book

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
26.3×-20.7×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
4.1×+0.5×
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
3.2×+1.9×
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
1.8×+0.9×
uniQure logo
uniQureQURE
6.8×-10.2×
Roivant Sciences logo
Roivant SciencesROIV
4.4×+2.8×

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Calculated from Biohaven’s reported figures.

Based on the most recent quarter.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's price / book?
Biohaven (BHVN) reported price / book of 9.8× in Q1 2026.
How has Biohaven's price / book changed year-over-year?
Biohaven's price / book increased by 3.9% year-over-year, from 9.5× to 9.8×.
What is the long-term trend for Biohaven's price / book?
Over 3 years (2022 to 2025), Biohaven's price / book has grown at a 154.0% compound annual growth rate (CAGR), from 1.8× to 28.8×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.